Although our primary mission is to work on behalf of Canadians living with HAE and other related angioedema, our plan recognizes our responsibility to the world—wide HAE community.

Canadians living with HAE and other related angioedema have worked diligently to gain access to the most advanced treatments. Work continues with our partners both in Canada and world—wide to further improve the standard of care available.

HAE Canada is a patient advocate group that acknowledges our responsibility to work with the International Patient Organization for C1 Inhibitor Deficiencies (HAEi) to further their mission of promoting cooperation, coordination and information sharing between HAE specialists and national patient associations in order to promote and facilitate the availability of effective diagnosis and management of HAE and other related angioedema throughout the world.